is tresiba a glp-1 Novo Nordisk's snags label boost that could sharpen its safety edge Tresiba: Package Insert / Prescribing
Description
51-OR: a phase 2, randomized, double-blind, placebo-controlled, dose-finding study of BI 456906 in people with overweight/obesity
They werent just eating less, but drinking less too
20, the firm surveyed more than 600 participants who are currently taking a GLP-1, considering the therapy or have taken it in the past but no longer do
[DOI] [PMC free article] [PubMed] [Google Scholar] 77.He Y, Huang Y, Xu H, Yang X, Liu N, Xu Y, et al
Bang-Berthelsen, C
